The forums approached these topics from the point of view of production process of different types of drugs. Presentations gave insight into the aseptic, solid and biopharmaceutical preparation factories from project design, construction, operation, verification to production process optimization, quality control and other contents.
The forum invited Ms. Zhang Hua, who is minister of GMP Department of Certification Center, Shanghai Food and Drug Administration, to summarize and analyze the common problems in 2010 version drug GMP certification process. Ms. Zhang answered questions and treated problems for the audience.
Gathering of Pharmaceutical Experts in China
Experts from Bristol-Myers Squibb, GlaxoSmithKline, Sino-Swed Pharmaceutical Corp.., Jiangsu Chia-Tai Tianqing Pharmacy., Tianjin Tasly Group., Beijing Tiantan Biological Products Corporation and other domestic and foreign pharmaceutical enterprises also shared their experience and made the interactive communication with live audience.
Automation Becomes A highlight Topic
Comparing with the previous pharmaceutical forums, the forum has added lots of bright spots in information and automation sub-forum, biopharmaceutical preparations sub-forum. With the pharmaceutical factory’s increasing demand for information and automation construction, the forum invited Wang Yingli, who is division chief of Information Center, State Food and Drug Administration, introduced the national policies, measures and focus of attention on “Drug Electronic Supervision”.
Automation specialists from Siemens, IBM, ABB, and others shared the advanced concept and project results in the aspect of information and automation control system construction. - Read on how China's administration supports the country's booming pharmaceutical industry on page 3!
Unfold for details of your consent
Stand vom 23.03.2021
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.